<DOC>
	<DOCNO>NCT00001028</DOCNO>
	<brief_summary>To compare safety efficacy aerosolized pentamidine dapsone prevention Pneumocystis carinii pneumonia ( PCP ) high-risk HIV-infected patient intolerant trimethoprim and/or sulfonamide . Both aerosolized pentamidine dapsone show prevent PCP , drug cause side effect . This study attempt determine drug efficacious prophylaxis PCP patient tolerate trimethoprim/sulfamethoxazole .</brief_summary>
	<brief_title>A Study Pentamidine Plus Dapsone Prevention Pneumocystis Carinii Pneumonia ( PCP ) HIV-Infected Patients Who Can Take Trimethoprim Sulfonamides</brief_title>
	<detailed_description>Both aerosolized pentamidine dapsone show prevent PCP , drug cause side effect . This study attempt determine drug efficacious prophylaxis PCP patient tolerate trimethoprim/sulfamethoxazole . Patients evenly divide two treatment arm receive either aerosolized pentamidine every 4 week dapsone orally three time weekly . Follow-up data collect every 3 month , patient clinically evaluate every 6 month . Patients develop PCP severe persistent study drug toxicity may switch alternative study drug clinician 's discretion . Average duration follow-up 2 year .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<mesh_term>Pentamidine</mesh_term>
	<criteria>Inclusion Criteria Patients must : HIV infection . CD4 count &lt; = 200 cells/mm3 &lt; = 15 percent total lymphocytes OR history prior PCP . History intolerance trimethoprim and/or sulfonamide . No active pneumocystosis . Patient guardian must sign informed consent . Pregnant patient eligible clinician 's discretion . Patients meet required laboratory value may eligible discretion clinician . Exclusion Criteria Concurrent Medication : Excluded : Any medication potential antiPCP activity . Patients follow prior condition exclude : Treatmentlimiting reaction pentamidine dapsone .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Pneumonia , Pneumocystis carinii</keyword>
	<keyword>Pentamidine</keyword>
	<keyword>Dapsone</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>AIDS-Related Complex</keyword>
</DOC>